IRC
Atreca, Inc.
Application Filed: 2016-10-07
Trademark Application Details
FIFTH EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87197041 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | R. Gwen Peterson |
| Attorney Docket Number | 1026225 |
| Law Office Assigned | M30 |
| Employee Name | PREET, KAMAL |
Timeline
| 2016-10-07 | Application Filed |
| 2017-03-07 | Published for Opposition |
| 2019-10-17 | Location: INTENT TO USE SECTION |
| 2019-10-17 | Status: Live/Pending |
| 2019-10-18 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Atreca, Inc. |
| Address | 500 Saginaw Dr., Suite 100 Redwood City DE 94063 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Research, design and development of diagnostics for predicting or monitoring the response of patients to therapeutics; research, design and development of biologics for predicting or monitoring the response of patients to therapeutics; research, design and development of combinations of such diagnostics and biologics; research, design and development of diagnostics for diseases in humans and animals, namely, infectious diseases, cancer, autoimmune and inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases; research, design and development of biologics for the treatment or prophylaxis of human and animal diseases, namely, infectious diseases, cancer, autoimmune and inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases; research, design and development of combinations of diagnostics and biologics for the treatment or prophylaxis of human and animal diseases, namely, infectious diseases, cancer, autoimmune and inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases |
| GS0421 | Research, design and development of diagnostics for predicting or monitoring the response of patients to therapeutics; research, design and development of biologics for predicting or monitoring the response of patients to therapeutics; research, design and development of diagnostics for diseases in humans, namely, infectious diseases, cancer, and respiratory diseases; research, design and development of biologics for the treatment of human diseases, namely, infectious diseases, cancer, and respiratory diseases |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-10-11 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-10-13 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-01-17 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2017-01-19 | 4 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2017-01-19 | 5 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-01-19 | 6 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-01-19 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-01-19 | 8 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-02-15 | 9 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-03-07 | 10 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-03-07 | 11 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-05-02 | 12 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2017-10-26 | 13 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2017-10-26 | 14 EXT1 S: |
| EXTENSION 1 GRANTED | 2017-10-26 | 15 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-10-28 | 16 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-05-01 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2018-05-01 | 18 EXT2 S: |
| EXTENSION 2 GRANTED | 2018-05-01 | 19 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-05-03 | 20 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-10-30 | 21 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2018-10-30 | 22 EXT3 S: |
| EXTENSION 3 GRANTED | 2018-10-30 | 23 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-11-01 | 24 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-04-10 | 25 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2019-04-10 | 26 EXT4 S: |
| EXTENSION 4 GRANTED | 2019-04-10 | 27 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-04-12 | 28 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-10-11 | 29 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-10-17 | 30 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2019-10-11 | 31 EXT5 S: |
| EXTENSION 5 GRANTED | 2019-10-17 | 32 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-10-18 | 33 EXRA E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-04-23 | 34 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-04-23 | 35 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-04-23 | 36 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-04-23 | 37 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-04-23 | 38 CHAN I:Incoming Correspondence |
| TEAS STATEMENT OF USE RECEIVED | 2020-05-01 | 39 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2020-05-01 | 40 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2020-05-09 | 41 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2020-05-22 | 42 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2020-05-23 | 43 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-06-30 | 44 R.PR A:Allowance for Publication |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-08-27 | 45 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-08-27 | 46 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-08-27 | 47 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-08-27 | 48 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-08-27 | 49 CHAN I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 